Intra-Cellular Therapies, Inc. Comparables

Find the most relevant public market comparables for Intra-Cellular Therapies, Inc., including EV/Revenue and EV/EBITDA multiples to help you make informed investment decisions.

Company Overview

A biopharmaceutical company focused on the discovery, development, and commercialization of small molecule drugs that address underserved medical needs primarily in neuropsychiatric and neurological disorders. The company develops novel drugs for treating diseases of the central nervous system, leveraging proprietary chemistry platforms to develop drugs for neurodegenerative diseases.

Business Model

Discovery, development, and commercialization of small molecule drugs for neuropsychiatric and neurological disorders.

Target Customers

Patients with neuropsychiatric and neurological disorders, healthcare providers, and health systems.

Specific Focus

Developing treatments for complex psychiatric and neurologic diseases using an intracellular approach.

Location

New York, New York

CEO

Sharon Mates

Industry

Life sciences

Sub Sector

Biotechnology

3yr Revenue Growth

1,936%

Public Market Comparables

Below are the key valuation metrics for companies similar to Intra-Cellular Therapies, Inc. in the Pharmaceuticals sector. These metrics can help you understand how the market values companies with similar business models and growth profiles.

Looking for a comprehensive compset for Intra-Cellular Therapies, Inc.? Our platform provides detailed analysis of Intra-Cellular Therapies, Inc.'s competitive landscape, including financial metrics, growth trends, and market positioning. Get access to the full Intra-Cellular Therapies, Inc. compset by trying our platform today.

EV/Revenue Multiple

Min

0.0x

Median

0.0x

Max

00.0x

Unlock actual values by trying our platform

View Full Details

EV/EBITDA Multiple

Min

00.0x

Median

00.0x

Max

00.0x

Unlock actual values by trying our platform

View Full Details
Screenshot of CompSetFinder showing Intra-Cellular Therapies, Inc. comps with valuation metrics like EV/Revenue, EV/EBITDA, and P/E

Unlock the Full Intra-Cellular Therapies, Inc. Compset

As a leading player in the Life sciences industry within the Pharmaceuticals sector, Intra-Cellular Therapies, Inc. operates in the specialized Biotechnology sub-sector. Understanding how Intra-Cellular Therapies, Inc. compares to its public market comps is essential for accurate valuation and strategic decision-making.

Our comprehensive analysis includes detailed comparables (compsets) featuring similar companies in the Biotechnology space, with complete financial metrics, growth trajectories, and competitive positioning insights that go beyond the surface-level data shown above.

Get Your Custom Comparable Analysis

Need a more detailed analysis of Intra-Cellular Therapies, Inc. and its public market comparables? Our platform provides comprehensive valuation metrics, growth analysis, and more.

Try CompsetFinder Free